Company news

Abbisko Cayman Limited news in 2022

Abbisko Cayman Limited's news releases, calls and decks from 2022, newest first.

View company

Abbisko Therapeutics Completed Dosing of First Patient for Its First-in-Class Highly Selective FGFR2/3 Inhibitor ABSK061

July 4, 2022

Decks in 2022